PB0970 E-learning Course as a Tool to Improve Awareness on the Management of Cancer Associated Thrombosis at a Single Institution

ISTH Academy, Faculty / Presenters, 407530

PB0971 Incidence of Cancer-Associated Thrombosis in Ambulatory Cancer Patients Not Receiving Thromboprophylaxis, a Prospective Cohort Study in Asian Population

ISTH Academy, Faculty / Presenters, 407531

PB0972 Venous Thromboembolism and Radiotherapy in Cancer Patients: A Systematic Review and Meta-Analysis

ISTH Academy, Faculty / Presenters, 407532

PB0968 Thrombo-Inflammatory Biomarkers and Coagulation Factors Contributes to the Hypercoagulable State in Lung Cancer Patients

ISTH Academy, Faculty / Presenters, 407533

PB0969 Treatment of Cancer Associated Venous Thromboembolism with Apixaban in Patients Receiving Concomitant TAXANES

ISTH Academy, Faculty / Presenters, 407534

PB0962 Assessing the Relationship between Thrombosis and Immune-Related Adverse Events in Patients with Lung Cancer Treated with Immune Checkpoint Inhibitor Therapy

ISTH Academy, Faculty / Presenters, 407535

PB0963 Clinical Outcomes of Anticoagulation for the Treatment of Thromboembolism (TE) in Elderly Cancer Patients

ISTH Academy, Faculty / Presenters, 407536

PB0964 Deep Venous Thrombosis in Women with Locally-Advanced Cervical Cancer: Dynamic Risk Modelling Score

ISTH Academy, Faculty / Presenters, 407537

PB0965 Delphi Survey of Canadian Physicians to Determine Optimal Anticoagulant Treatment Approaches for Patients with Cancer and Splanchnic Venous Thrombosis

ISTH Academy, Faculty / Presenters, 407538

PB0966 Machine Learning Model for Bleeding Prediction in Patients with Cancer-Associated Thrombosis Receiving Anticoagulation Therapy

ISTH Academy, Faculty / Presenters, 407539

PB0967 Real World Management of Cancer Associated Thrombosis: How Many Patients Actually Receive DOACs?

ISTH Academy, Faculty / Presenters, 407540

PB0961 Towards Cancer Patient Empowerment for Optimal Use of Antithrombotic Therapy at the End of Life: A Research Protocol for the Development and Implementation of the SERENITY Shared-Decision Support Tool

ISTH Academy, Faculty / Presenters, 407541

PB0953 An Updated Systematic Review and Meta-Analysis of the Safety and Efficacy of Factor Xa Inhibitors versus Low Molecular Weight Heparin Therapy for Treatment of Cancer Associated Venous Thromboembolism

ISTH Academy, Faculty / Presenters, 407542

PB0954 Endothelial Dysfunction in Myeloproliferative Neoplasms Debuting with Splanchnic Vein Thrombosis

ISTH Academy, Faculty / Presenters, 407543

PB0956 Performance of Score in CAT Prediction in the Setting of Different Subtypes of Digestive Cancer from ONCOCIP Database

ISTH Academy, Faculty / Presenters, 407544

PB0957 The Application of Existing Risk Assessment Models (RAMs) to Predict the Occurrence of Venous Thromboembolic Events among Patients with Classic Hodgkin's Lymphoma

ISTH Academy, Faculty / Presenters, 407545

PB0958 The Efficacy of Thromboprophylaxis against Chemotherapy- Associated Thromboembolic Events in Germ Cell Testicular Cancers: A Meta-Analysis of Comparative Studies

ISTH Academy, Faculty / Presenters, 407546

PB0959 The Pooled Estimate of Thromboembolic Events and Their Patterns in Advanced Germ Cell Testicular Cancers: A Proportional Meta-Analysis

ISTH Academy, Faculty / Presenters, 407547

PB0960 Thrombosis and Intracranial Hemorrhage in Patients with Metastatic Brain Tumors Treated with Immune Checkpoint Inhibitors

ISTH Academy, Faculty / Presenters, 407548

PB0951 Are Efficacy and Safety of Direct Oral Anticoagulants Modified by Fragility Characteristics in Patients with Cancer Associated Thrombosis (CAT)? A Meta-Analysis of Randomized Controlled Trials

ISTH Academy, Faculty / Presenters, 407549

PB0944 Association of Chemotherapy and Other Therapeutic Agents with Venous Thromboembolism in Elderly Patients with Acute Lymphocytic Leukemia in the United States

ISTH Academy, Faculty / Presenters, 407550

PB0945 Effect of Drug Interactions with Apixaban on Clinical Outcomes in Cancer Patients with Venous Thromboembolism

ISTH Academy, Faculty / Presenters, 407551

PB0946 Risk of Venous and Arterial Thromboembolism in Recurrent/ Metastatic Colorectal Cancer Patients Receiving First-Line Cetuximab-Based Combination Therapy: A Korean Population-Based Study

ISTH Academy, Faculty / Presenters, 407552

PB0947 The Risk of Venous Thromboembolism in Primary Central Nervous System Lymphoma: A Systematic Review

ISTH Academy, Faculty / Presenters, 407553

PB0948 Presence of Intrathrombus Cancer Cells as Vascular Wall Invasion and Cell Cluster Patterns in Human Cancer-Associated Venous Thromboembolism

ISTH Academy, Faculty / Presenters, 407554

PB0949 Treatment Patterns in an Unselected Sample of Patients with Cancer Associated Thrombosis - Data from the TROLL Registry

ISTH Academy, Faculty / Presenters, 407555

PB0950 Using a Network Meta-Analysis (NMA) to Estimate the Risk of Venous Thromboembolism (VTE) by Cancer Site

ISTH Academy, Faculty / Presenters, 407556

PB0937 Association of Fibrinolytic Potential and Risk of Mortality in Cancer Patients

ISTH Academy, Faculty / Presenters, 407557

PB0938 Direct Oral Anticoagulants versus Low Molecular Weight Heparins in Patients with Brain Tumor Receiving Therapeutic Anticoagulation: A Systematic Review and Meta-Analysis

ISTH Academy, Faculty / Presenters, 407558

PB0939 Effect of Pegylated Asparaginase on Coagulation Parameters and Thrombin Generation in Adults with Acute Lymphoblastic Leukemia

ISTH Academy, Faculty / Presenters, 407559

PB0940 Guideline Implementation Successes and Barriers to Prevent Cancer Associated Thrombosis in Community and Rural Cancer Clinics

ISTH Academy, Faculty / Presenters, 407560

PB0941 Pancreatic Cancer Cells and Derived Microvesicles Induce Thrombosis in Coagulation Factor Deficient Mouse Models

ISTH Academy, Faculty / Presenters, 407561

PB0942 Prediction of Venous Thromboembolism in Patients with Cancer Using Neural Network

ISTH Academy, Faculty / Presenters, 407562

PB0943 Results of a Clinical Audit of Intermediate Dose Low Molecular Weight Heparin for Thromboprophylaxis in Newly Diagnosed Multiple Myeloma Patients

ISTH Academy, Faculty / Presenters, 407563

PB0927 Bleeding and Thrombosis in Patients Receiving Chimeric Antigen Receptor T-Cell Therapy

ISTH Academy, Faculty / Presenters, 407564

PB0928 Competing Risks Analysis of Recurrent Venous Thromboembolism (VTE) and Bleeding on Anticoagulation in Patients with Cancer- Associated VTE

ISTH Academy, Faculty / Presenters, 407565

PB0929 Genetic Aberrations Create Different Procoagulant Landscapes across Cancers

ISTH Academy, Faculty / Presenters, 407566

PB0930 HIF-1 Inhibition Reduces Venous Thrombosis in a Murine Polycythemia Vera Model

ISTH Academy, Faculty / Presenters, 407567

PB0931 Long-Term Performance of a Clinical-Genetic Risk Score of Venous Thromboembolism (VTE) in Cancer Patients

ISTH Academy, Faculty / Presenters, 407568

PB0932 miR-5683 from Gastric Cancer Cells Inhibits Endothelial TFPI Contributing to Thrombotic Risk in Patients with Gastric Cancer

ISTH Academy, Faculty / Presenters, 407569

PB0933 Somatic CALR1 vs. CALR2 Mutation in Patients with Essential Thrombocythemia and the Risk of Thrombosis. A Systemic Review and Meta-Analysis

ISTH Academy, Faculty / Presenters, 407570

PB0934 The Safety and Efficacy of Direct Oral Anticoagulants (DOACs) versus Low Molecular Weight Heparin (LMWH) in the Treatment of Thromboembolism (TE) in Patients with Hematological Malignancies

ISTH Academy, Faculty / Presenters, 407571

PB0935 To Inform or not to Inform about Cancer-Associated Thrombosis: A Qualitative Study on Communication between Healthcare Professionals and Patients with Lung Cancer

ISTH Academy, Faculty / Presenters, 407572

PB0925 The Impact of Clinicopathologic Factors on the Risk of Chemotherapy- Associated Thromboembolic Events in Germ Cell Testicular Cancers: A Pooled Analysis

ISTH Academy, Faculty / Presenters, 407573

PB0926 Venous Thromboembolism and Risk of Depression in Patients with Hematological Cancer: A Population-Based Cohort Study

ISTH Academy, Faculty / Presenters, 407574

PB0917 Stratification of Risk Factors of Lung Cancer-Associated Venous Thromboembolism and Determining the Critical Point for Preemptive Intervention: An Evidence Synthesis Approach

ISTH Academy, Faculty / Presenters, 407575

PB0918 Clinical Presentation and Outcomes of Patients with Cancer- Associated Isolated Distal Deep Vein Thrombosis

ISTH Academy, Faculty / Presenters, 407576

PB0919 High Rates of Bleeding in Unselected Patients with Cancer: Results from a Prospective Cohort Study

ISTH Academy, Faculty / Presenters, 407577

PB0920 Mortality and Clinical Outcomes of Incidental versus Symptomatic Pulmonary Embolism among Cancer Patients

ISTH Academy, Faculty / Presenters, 407578

PB0921 Patients with Non-CVC Symptomatic Venous Thrombotic Events Have Significantly Inferior Survival Outcomes in Pediatric Cancer Patients: A Population-Based Study

ISTH Academy, Faculty / Presenters, 407579

PB0923 Treatment and Outcomes of Cancer-Associated Thrombosis, from “Traditional” Anticoagulation Options to Direct Oral Anticoagulants: A Ten-Year Experience

ISTH Academy, Faculty / Presenters, 407580

PB0924 Venous Thromboembolism Risk in Lung Cancer Patients Receiving First-Line Immune Checkpoint Inhibitor Versus Chemotherapy

ISTH Academy, Faculty / Presenters, 407581

PB1458 Thromboembolic (TE) Events in Cold Agglutinin Disease (CAD): Post-Hoc Analysis PRE- and ON-Sutimlimab Treatment in the Phase 3 CARDINAL and CADENZA Studies

ISTH Academy, Faculty / Presenters, 407582

PB1447 Factor V Leiden: An Independent, Gender-Dependent Risk Factor for Venous Thromboembolism

ISTH Academy, Faculty / Presenters, 407583

PB1448 Genetic Polymorphisms in Varicose Veins with and without Thrombosis

ISTH Academy, Faculty / Presenters, 407584

PB1442 Clinical Significance of PAI-I, F2 Thr165Met Genes Polymorphisms in Pregnant Women with a History of Thrombosis

ISTH Academy, Faculty / Presenters, 407585

PB1443 Detection of Genetic Chimerism for Thrombogenic Variants in a Liver Transplant Patient

ISTH Academy, Faculty / Presenters, 407586

PB1439 Diversity of Hereditary Protein C Deficiency in North France: A Genotype-Phenotype Correlation

ISTH Academy, Faculty / Presenters, 407587

PB1440 Lysis of In Vitro Whole Blood Clots is Altered in Sickle Cell Disease

ISTH Academy, Faculty / Presenters, 407588

PB1441 The Risk of Recurrent Venous Thromboembolism of Patients with Homozygous or Double Heterozygous Factor V Leiden and/or Prothrombin G20210A Mutation: A Prospective Cohort Study

ISTH Academy, Faculty / Presenters, 407589

PB0922 Predictive Scores of Thrombosis and Bleeding Complications in Newly-Diagnosed Acute Myeloid Leukemia Patients

ISTH Academy, Faculty / Presenters, 407590

PB0450 Does Iliac Vein Stenting Reduce the Severity of Post-Thrombotic Syndrome? Progress on an Ongoing Multicenter Randomized Controlled Trial

ISTH Academy, Faculty / Presenters, 407591

PB0449 Impact of Self-Reported Race on Villalta Scale Scores and Correlation with Venous Disease Specific Quality of Life: An Exploratory Analysis of the ATTRACT Trial

ISTH Academy, Faculty / Presenters, 407592

PB0448 Fibrin Clot Properties Identify Patients that Benefit from Catheter- Directed Thrombolysis: A Post Hoc Analysis of the CAVA Trial

ISTH Academy, Faculty / Presenters, 407593

PB0447 Incidence of Chronic Thromboembolic Pulmonary Hypertension after Acute Pulmonary Embolism: An Update of the Literature

ISTH Academy, Faculty / Presenters, 407594

PB0444 Residual Pulmonary Vascular Obstruction is Associated with Prothrombotic Fibrin Clot Phenotype in Patients Following Pulmonary Embolism

ISTH Academy, Faculty / Presenters, 407595

PB0445 Ultrasound Shear Wave Elastography Evaluation of Acute Deep Vein Thrombosis as a Predictor for Thrombus Resolution

ISTH Academy, Faculty / Presenters, 407596

PB0955 Factors Associated with Thrombo-Hemorrhagic Deaths in Patients with Acute Promyelocytic Leukemia Treated with Arsenic Trioxide and All-trans Retinoic Acid

ISTH Academy, Faculty / Presenters, 407597

PB1004 Clinical Performance Evaluation of Two New Stago Systems for Protein C Levels Determination: sthemO PC Clot and sthemO PC Chrom on sthemO 301 Analyzer

ISTH Academy, Faculty / Presenters, 407598

PB1003 The Factor V HR2 Haplotype and the Risk of Venous Thromboembolism (VTE): A Single Center Study

ISTH Academy, Faculty / Presenters, 407599

PB0998 Clinical Performance Evaluation of New Stago Systems for Protein S Levels Determination: sthemO PS Clot and sthemO PS Free on sthemO 301 Analyzer

ISTH Academy, Faculty / Presenters, 407600

PB0999 Hereditary Thrombophilia Workups in the Pediatric Population: A Quality Improvement Initiative

ISTH Academy, Faculty / Presenters, 407601

PB0995 Novel Thrombophilia - Prothrombin Belgrade Variant

ISTH Academy, Faculty / Presenters, 407602

PB0996 Thrombotic Tendency in a Family with Protein C Deficiency Measured with an Automated Thrombin Generation Analyzer

ISTH Academy, Faculty / Presenters, 407603

PB0997 Utility of Thrombin Generation Assay for Inherited Thrombophilia Screening

ISTH Academy, Faculty / Presenters, 407604

PB0994 Intronic Exploration of PROC in Patients with Unexplained Protein C Deficiencies

ISTH Academy, Faculty / Presenters, 407605

PB0990 Changes in Thrombin Generation Parameters in Newly Diagnosed Multiple Myeloma Patients in Response to Anti-Myeloma Therapy

ISTH Academy, Faculty / Presenters, 407606

PB0991 Clinical Performance Evaluation of a New Stago System for Antithrombin Levels Determination: sthemO AT on sthemO 301

ISTH Academy, Faculty / Presenters, 407607

PB0993 Thromboelastometry (ROTEM) in Detection of Hypercoagulability in Patients Referred for Thrombophilia Screening

ISTH Academy, Faculty / Presenters, 407608

PB0989 The Efficacy and Safety of Direct Oral Anticoagulants in 50 Patients with Venous Thromboembolism and Severe Thrombophilia: A Multicenter Study

ISTH Academy, Faculty / Presenters, 407609

PB0988 Homozygous Protein S Deficiency in Siblings

ISTH Academy, Faculty / Presenters, 407610

PB0987 Hereditary Antithrombin Deficiency Pilot Project Registry from the American Thrombosis and Hemostasis Network (ATHN)

ISTH Academy, Faculty / Presenters, 407611

PB0985 Cure of Congenital Purpura Fulminant by Neonatal Genome Editing to Express an Engineered Protein C in Mice

ISTH Academy, Faculty / Presenters, 407612

PB0986 Genotype-Phenotype Correlation in Belgian Patients with Inherited Protein C Deficiency

ISTH Academy, Faculty / Presenters, 407613

PB0455 Bilateral Asynchronous Adrenal Infarction in JAK2-Positive Essential Thrombocythemia

ISTH Academy, Faculty / Presenters, 407614

PB0454 Incidence and Predictors of Portal Vein Thrombosis and Mortality in Patients with Liver Cirrhosis: A Retrospective Matched Case-Control Two-Centre Study

ISTH Academy, Faculty / Presenters, 407615

PB0453 Efficacy and Safety of Direct Oral Anticoagulants in Splanchnic Vein Thrombosis: A Pooed Analysis of Literature Studies

ISTH Academy, Faculty / Presenters, 407616

PB0452 Glycemic Control and Plasma Levels of Pro-Inflammatory and Pro- Thrombotic Biomarkers in Diabetic Patients Presenting with Acute Pulmonary Embolism

ISTH Academy, Faculty / Presenters, 407617

PB1029 Exophthalmos Revealing a Rare Cause of Thromboembolic Disease

ISTH Academy, Faculty / Presenters, 407618

PB1027 Delayed Diagnosis and Treatment of Deep Vein Thrombosis-an Underrecognized Factor for Its Related Complications?

ISTH Academy, Faculty / Presenters, 407619

PB1025 Evaluation of a New Stago System for D-Dimer Levels Determination: SthemO DDi on sthemO 301

ISTH Academy, Faculty / Presenters, 407620

PB1022 MicroRNAs Expression before and after Exercise in Patients with Residual Thrombosis after Pulmonary Embolism

ISTH Academy, Faculty / Presenters, 407621

PB1023 Seasonal Variations Regarding Incidence of CTPA Confirmed Pulmonary Embolism in Belfast, N Ireland, from 2014 to 2022

ISTH Academy, Faculty / Presenters, 407622

PB1016 Case-Control Study on Dynamic Upper Limb Ultrasound and Biomarkers in Idiopathic Upper Extremity Deep Vein Thrombosis

ISTH Academy, Faculty / Presenters, 407623

PB1017 Incidence of Pulmonary Embolism-Related Death in Clinical Inpatients Based on ISTH Standardized Recommendation Criteria

ISTH Academy, Faculty / Presenters, 407624

PB1018 Inter-Relationship of Adhesion Molecules with Thrombo-Inflammatory Processes in Pulmonary Embolism

ISTH Academy, Faculty / Presenters, 407625

PB1019 Real-Time Identification of Patients Diagnosed with Pulmonary Embolism in the Emergency Department Using Automated Natural Language Processing of Computed Tomography Reports

ISTH Academy, Faculty / Presenters, 407626

PB1020 Simultaneous Generation of Thrombin and Plasmin in Patients with Deep Vein Thrombosis and High Levels of Lipoprotein (a)

ISTH Academy, Faculty / Presenters, 407627

PB1021 Using an Age and Fibrinogen Levels Adjusted D-Dimer Cutoff Significantly Improves the Specificity of D-Dimer Testing for Excluding Pulmonary Embolism

ISTH Academy, Faculty / Presenters, 407628

PB1013 Evaluation of the Diagnostic Performance of Three D-Dimer Assays in Patients with Suspected Deep Vein Thrombosis

ISTH Academy, Faculty / Presenters, 407629